The Engine has co-led by $16m seed round for Cellino, which is working on a process to automate the generation of stem cells at scale.
Cellino, a US-based personalised regenerative medicine developer based on research at Harvard University, completed a $16m seed round on Monday co-led by The Engine, the venture firm backed by Massachusetts Institute of Technology and Harvard.
Khosla Ventures co-led the round, which also featured Humboldt Fund and 8VC.
Cellino is working on an artificial intelligence-guided laser editing platform to enable an automated process that generates autologous induced pluripotent stem cells at scale.
Nabiha Saklayen, chief executive and…
